Today marks the start of RSNA 2020, the annual meeting of the Radiological Society of North America. I participated in my first RSNA 35 years ago and I am super excitedas I am every yearto reconnect with my radiology colleaguesand friendsand learnabout the latestmedical and scientific advances in our field. Of course, RSNA will be very different this year. Instead of traveling to Chicago to attend sessions and presentations, and wander the exhibits, Ill experience it all online. While I will miss the fun, excitement, and opportunities to connect that come with being there in person, I am amazed by what a rich and comprehensive conference the organizers of RSNA 2020 have put together using the advanced digital tools that we have at hand now.
It would be an understatement to say that this has been a year in which nearly everything is very different. From the tragic loss of life and rampant sickness to the economic disruption and the impact on our professions and our childrens education, so much of what we have been through because of COVID-19 has been extremely difficult. But the resilience of the response that so many people and institutions have shown in the face of all these challenges has been remarkable. And if it is possible to say there has been some good in all this, it would have to be the unprecedented transformation of the global healthcare ecosystem as hospitals, clinicians, and researchers have embraced a new generation of advanced digital health technologies that have helped them respond to the coronavirus crisis and laid the foundation for a more effective, affordable, and equitable future for healthcare.
As we move forward and the digital transformation of healthcare continues to accelerate, I see three significant trends that will influence the future of health and wellness.
One is the rapid emergence of virtual care through digital tools such as telehealth and remote monitoring that have made it safer and more convenient for patients to connect with their doctors during the pandemic, and that is empowering individuals to take charge of their health in entirely new ways. Virtual care has the capacity to personalize, accelerate, and augment treatment and prevention, saving time and money while improving outcomes. The ability to engage patients without requiring an in-person visit to a clinic will help ensure that they receive the right level of care and enable healthcare facilities to better manage the flow of patients into clinics and emergency rooms.
The second trend is the growing clarity of the promise of AI-driven precision medicine to serve as a major catalyst for improving health outcomes. As platforms for precision medicine and real-world evidence mature, well see exciting opportunities to improve treatment and prevention as we personalize patient care and transform how we diagnose infectious disease, cancer, and autoimmune disorders.
And, finally, where healthcare organizations have long been reluctant to move data offsite due to security, trust, and privacy concerns, we have seen a historic shift to the cloud over the last nine months. Now, driven by regulatory changes, the massive increase in medical data, and the critical need to access and analyze all that data by providers, payers, public health agencies, and researchers, its clear to everyone that moving to the cloud is both essential and hugely beneficial, both to providers and to patients.
As part of Microsofts ongoing commitment to help healthcare customers and partners continue to make progress toward recovery and build more resilient and effective systems of care, in late October we announced the general availability of Microsoft Cloud for Healthcare. This powerful industry-specific solution provides integrated capabilities for automated and efficient high-value workflows, and advanced data analysis functionally for structured and unstructured data so that healthcare organizations can truly transform information into insight and insight into action.
Built on the trusted capabilities of Microsoft 365, Microsoft Azure, Microsoft Dynamics 365, and Microsoft Power Platform, Microsoft Cloud for Healthcare is designed to enhance patient engagement to make it easier for patients to interact with caregivers, empower health team collaboration to facilitate more efficient and rich real-time communication and collaboration across the care continuum, and improve clinical and operational data insights with the ability of healthcare organizations to connect data from across their systems to predict risk and help improve patient care and operational efficiencies. Our robust partner ecosystem extends the power of Microsoft Cloud for Healthcare by building and extending advanced health solutions to meet the most demanding challenges in healthcare.
All of this makes it a particularly exciting time to be a radiologist. In many ways, our field has always been at the forefront of advances in the technologies that improve the movement, management, and analysis of large amounts of health data. This shouldnt really be a surprise, given that medical imaging accounts for nearly three-quarters of all health data, and analyzing 3D medical images can require up to 50 GB of bandwidth a day.
At Microsoft, streamlining the flow of health data, including medical imaging data, has been a significant focus of our work over the past few years. With the release of the Medical Imaging Server for DICOM (Digital Imaging and Communications in Medicine) in September, we offer developers powerful tools to ingest and persist medical imaging data in the cloud. Elevating interoperability, this is the first cloud technology to bring together DICOM data standard and FHIR (Fast Healthcare Interoperability Resources) which allows for persisting medical imaging metadata alongside other clinical data and sets the stage for multiple scenarios in research and diagnosis which may be too difficult or expensive to execute today.
Now, with Project InnerEye and the open-source InnerEye Deep Learning Toolkit, were making machine learning techniques available to developers, researchers, and partners that they can use to pioneer new approaches by training their own ML models, with the aim of augmenting clinician productivity, helping to improve patient outcomes, and refining our understanding of how medical imaging can be combined with other types of data to advance personalized medicine.
Learn more about our latest medical imaging offerings at the RSNA industry hour lunch and learn on December 3, 12:30 PM 1:30 PM Central Time.
Reimagining an industry that is as complex and touches as many lives as healthcare is a massive undertaking and at Microsoft, we have the privilege of working with amazing partners who stand at the forefront of innovation and progress in medical imaging technology.
Our partners are building transformative solutions to address some of the most difficult challenges in medical imaging. The amount of data generated by medical diagnostic imaging and connected devices is growing exponentially. Healthcare stakeholders, therefore, need effective ways of handling these data at scale.
This prompted Siemens Healthineers to build a dedicated cloud environment for Healthcare: The teamplay digital health platform. Through a certified gateway, the teamplay receiver, health data from connected medical devices can be aggregated. The teamplay cloud infrastructure is based on Azure, allowing secured processing of data within or outside a hospitals network.
GE Healthcares Centricity Universal Viewer Zero Footprint (ZFP) connects advanced diagnostic tools and system-wide image management platforms across the care continuum to help healthcare organizations improve diagnostic speed and confidence. ZFP users can now open Microsoft Teams with one click and share studies with other clinicians via the secure and compliant channels.1
SOPHiA GENETICS, the company pioneering the Data-Driven Medicine movementtrusted by over 1000 healthcare institutions in 85 countriesis highlighting their radiomics capabilities through the universal SOPHiA Platform for oncology and COVID CT imaging. Radiomics transforms standard medical imaging into mineable data assets that can be analyzed and combined with genomic data for improved decision support of precision medicine. SOPHiA Radiomics Solutions offer comprehensive workflows for multiple research and disease indication needs. SOPHiA multimodal platform is deployed on Microsoft Azure Cloud.
Microsoft and Sectra are partnering on cloud-based enterprise imaging and AI. In our joint RSNA webinar, Reap the benefits of enterprise imaging in the cloud with Microsoft & Sectra on December 3, we will introduce the brand new all-Azure and hybrid Microsoft Azure Stack offering as well as a demo of how Teams integration will help radiologists to cope in the new virtual world. We will hear Judy Bartlett from our joint customer John Muir share her experiences about moving from on-prem to running the Sectra Enterprise Imaging Solution as a Service on Azure.
With the imminent release of a new version of iConnect Enterprise Archive, IBM Watson Health will start to bring to market solutions that support a containerized deployment, in addition to VMWare, on both the IBM Cloud and Azure. The containerization of this portfolio is one of IBM Watson Healths key initiatives, starting with their VNA foundation and leveraging IBMs Red Hat OpenShift technology to ensure build once and deploy anywhere to be cloud native and agnostic.
With NVIDIA Clara Imaging, developers and researchers have the ability to accelerate data annotation, build domain-specialized AI models, and deploy intelligent imaging workflows with state-of-the-art pre-trained models and reference applications. Working closely with Azure, these innovators can jumpstart their development in the cloud and also address tough medical imaging challenges faster.During the current pandemic, our partnership is heavily accelerating progress Research in drug discovery (UC, Riverside; UCB Covid Moonshot) using GPUs on Azure for quantum mechanics model as well as using AI for SARS COVID-19 risk evaluation in Italy (Hospital San Raffaele, Milan). This partnership also enables the development and deployment of smart hospital solutions, running on NVIDIA Clara Guardian and Azure.
And finally,Flywheel is a cloud-scale informatics platform for biomedical research and collaboration. What is exciting about their differentiated work is the ability to securely leverage cloud at the edge with Microsoft Azure Stack Hub and transform these image analytics with Microsoft AI enabling tools and Flywheels depth in medical imaging data management and automated workflows.
Microsoft is the only cloud that extends to the edge from Microsoft Azure Edge Zone for 5G to Microsoft Azure Sphere for security. Were removing all barriers by covering all security and data sovereignty concerns in the cloud. With over 168,000 partners around the world, the network for innovation and collaboration runs deep. We cannot wait to see how together we will build solutions that transform healthcare around the world.
For more information on Microsoft Cloud for Healthcare, AI imaging tools, or to learn more about partnership visit the Microsoft virtual booth at RSNA or connect with us at our featured demo on November 29, 2:00 PM 2:30 PM Central Time.
[1] Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not for sale. Not cleared or approved by the U.S. FDA or any other global regulator for commercial availability.
Go here to see the original:
Medical imaging, AI, and the cloud: what's next? - Microsoft Industry Blogs - Microsoft
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022
- AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions... - June 8th, 2022
- Time to Rethink Metformin as First-Line Therapy? Perspective from ADA 2022 - Endocrinology Network - June 8th, 2022
- PreludeDx Presents New DCISionRT Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting - 69News WFMZ-TV - June 8th, 2022
- BITS Pilani Hyderabad to conduct 'Precision Medicine 2022' event tomorrow - United News of India - June 8th, 2022
- Global Laboratory Information Systems (LIS) Market to Reach US$2.4 Billion by the Year 2026 - Yahoo Finance - June 8th, 2022
- Medical Nutrition Market Promising Growth Opportunities and Forecast 2027 - Digital Journal - June 8th, 2022
- 57% of Organizations in India are at the Startup Stage of Genomics High-Performance Computing Infrastructure - APN News - June 8th, 2022
- Cellworks Singula TRI Provides Personalized OS and PFS Predictions for 18 NCCN Guideline GBM Therapies - StreetInsider.com - June 8th, 2022
- Inspiration for the laboratory of tomorrow - Chemie.de - June 8th, 2022
- Global Nanomaterials in Personalized Medicine Market (Impact Of COVID-19) Growth, Overview With Detailed Analysis 2022-2028 Queen Anne and Mangolia... - May 8th, 2022
- The global biomarkers market is expected to grow at a CAGR of 11.44%. - Yahoo Finance - May 8th, 2022
- Bioinformatics Market Size, Share, And Trends Analysis Report, By Application (Drug Development, Protein Function Analysis, Gene Therapy, Molecular... - May 8th, 2022
- Link between EBV and MS may give clues to the cause of long COVID - The Arizona Republic - May 8th, 2022
- Improving Cell Cultures with Thermoresponsive Coatings - Genetic Engineering & Biotechnology News - May 8th, 2022
- Reevaluating, Reimagining, And Reinventing Healthcare: Innovation In A Post-Pandemic World - Forbes - May 8th, 2022
- Study of Cancer Genetics to Help with Targeted Treatment - VOA Learning English - May 8th, 2022
- Increased demand for Molecular diagnostics after the COVID-19 outbreak - The Financial Express - May 8th, 2022
- CIOs' 5-year plans for precision medicine and emerging technologies - Healthcare IT News - January 30th, 2022
- SeqOne Genomics Closes 20M Series a to Accelerate the Deployment of Its Genomic Medicine Platform - Business Wire - January 30th, 2022
- Study: In IBS patients, cognitive behavioral therapy modulates the brain-gut microbiome and helps relieve symptoms - UB News Center - January 30th, 2022
- (New Report) Digital Genome Market In 2022 : The Increasing use in Diagnostics, Agriculture & Animal Research, Personalized Medicine, Drug... - January 30th, 2022
- Silencing a faulty gene may uncover clues to rare forms of ALS - National Institutes of Health - January 30th, 2022
- Plants, Bioprinting and Orbital Plumbing Fill Crew's Thursday Schedule - NASA - January 30th, 2022
- ClarityX DNA: The Key to Tackling Seasonal Affective Disorder - PR Web - January 30th, 2022